Metabolic SyndromePrevMetSynNCT01959763
Prevention of the Metabolic Syndrome by New Lifestyle Intervention Methods
A study testing Weight loss counseling program in people with Metabolic Syndrome and Obesity, run by University of Oulu at 1 site in Finland.
Trial summary
This intervention aims to reduce obesity by using new type of nutritional and lifestyle therapy and in parallel, tailored persuasive information and communications technology (ICT)-technology based application. The study hypothesis is that obesity cannot be reduced just by distributing nutritional information. Read more about this study
- Who is it for?
- Ages 20 to 60 years
- Conditions the study is for
- Metabolic Syndrome, Obesity, Overweight
- What is being tested?
- Weight loss counseling program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 574 participants
- Where
- 1 siteFinland
- Study dates
- Feb 2013to Dec 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- BMI 27-35
Who cannot join
- Other concurrent weight loss programs
- Disease which prevents weight loss
- Medication which affects on weight loss
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Prevention of the Metabolic Syndrome by a Lifestyle Intervention - an Application of the New Intervention Methods in the Primary Health Care.
This intervention aims to reduce obesity by using new type of nutritional and lifestyle therapy and in parallel, tailored persuasive information and communications technology (ICT)-technology based application. The study hypothesis is that obesity cannot be reduced just by distributing nutritional information. Instead, by influencing also the eating behavior, permanent lifestyle changes can be achieved. The effect of the therapy along the time-line, the health information literacy of the study persons and the changes in it will be studied at different phases of the intervention. The research will be carried out in three main groups of different levels of nutritional therapies with a parallel ICT-intervention and control group for each main group (altogether six groups).
Read the detailed description
The research objectives of this study: 1) to find the best counseling methods for improving eating behavior (group counseling, tailored web-based counseling), 2) to find the predictors of successful lifestyle changes and weight loss, 3) to find the associations with biological and psychological eating behavior regulation system, 4) to study the long-term effects of the intervention, 5) to investigate the changes to the medications after the intervention . The study hypothesis is that new theoretically valid cognitive-behavioral-therapy -based counseling methods in combination with ICT support based on persuasive design improve eating behavior, weight loss and self-efficacy and reduce risk factors for the metabolic syndrome, type 2 diabetes, coronary heart disease and musculoskeletal factors.
The study population consists of participants with overweight or obesity and at least one risk factor of metabolic syndrome (MetSyn). A population-based sample of 600 participants living in the Oulu area (approx. 200 000 habitants) is collected with the help of the Finnish Population Register Centre.
Inclusion criteria include also the ability to use basic ICT technology (email etc.). Exclusion criteria are certain uncontrolled health factors, such as abnormal laboratory values (thyroid, kidney and liver function tests) or clinically significant illness with contraindication for weight loss or physical activity.
Study visits are at baseline, 1, 2 and 5 years. At the study visit blood samples are drawn at the research laboratory of the Oulu University Hospital. Along with the timeline of the visits the eating behaviour factors (emotional eating, uncontrolled eating and cognitive restraint), health information literacy (HIL), nutrition habits, smoking, alcohol consumption, medication and previous diseases are recorded by a detailed questionnaires sent to study persons by e-mail. The blood pressure, waist diameter, height and weight are also measured during the visit. All the operations have been described in detail and accepted by the regional Ethics Committee of the Northern Ostrobothnia.
The randomization process is two-phased. First the subjects who are included in the study are randomized into 2 different kinds of lifestyle face-to-face counselling groups and one control group. After that they are randomized into users or non-users of the web-based ICT-program "Onnikka". As a summary, there are six different counselling groups: 1) Intensive group counselling, 2) Intensive group counselling with Onnikka, 3) Short term group counselling, 4) Short term counselling with Onnikka, 5) Control group (no intervention at all), and 6) Only Onnikka.
A linear mixed-effect model (LMM) (as primary analysis), where group (six study arms) and time were fixed effect factors are used to examine the differences in weight from baseline to 1, 2 and 5 years adjusting for age and sex. Primary analysis and sensitivity analyses are based on intention-to-treat principles. Primary analysis are also used to examine the differences between ICT groups and non-ICT groups. Group and time interaction are included in the model to examine whether mean change over time is different between groups. If data include missing values, they will be assumed to be completely at random. The same model is used with imputed values (both last observation carried forward (LOCF) and return-to-baseline (RTB) where data are missing and for completers as sensitivity analyses. Area Under the Curve (AUC) analysis is performed to integrate the effect interventions on the weight reduction over the different time points.
- Conditions
- Metabolic Syndrome, Obesity, Overweight, Cardiovascular Disease
- Being tested
- Weight loss counseling program
- Keywords
- Metabolic syndrome, obesity, overweight, weight loss intervention, cognitive behavioral therapy, ICT intervention, cardiovascular disease, persuasive systems design
- Medical subject headings
- Metabolic Syndrome, Obesity, Overweight, Cardiovascular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Weight loss counseling programBehavioural
Also called PrevMetSyn, Prevent Metabolic Syndrome
Randomized study persons are given either one of the two different methods of weight loss counseling program without ICT or with ICT-based counseling. As a control for the study groups one group is receiving only ICT-based counseling and one group does not receive any of the counseling methods.
| Study group | Role | What they receive |
|---|---|---|
| Weight loss counseling with ICT intervention | Experimental | Cognitive behavioral therapy-based weight loss counseling program including 8 group visits. Participant have also persuasive ICT support. Receives: Behavioral: Weight loss counseling program |
| Weigth loss counseling | Experimental | Cognitive behavioral therapy-based weight loss counseling program including 8 group visits. Receives: Behavioral: Weight loss counseling program |
| ELVIRA-based weight loss counseling with ICT intervention | Experimental | Weight loss counseling program based on 2 group visits of ELVIRA counseling method. Participant have also persuasive ICT support. Receives: Behavioral: Weight loss counseling program |
| ELVIRA-based weight loss counseling | Experimental | Weight loss counseling program based on 2 group visits of ELVIRA counseling method. Receives: Behavioral: Weight loss counseling program |
| ICT-based weight loss counseling | Experimental | ICT-based weight loss counseling program with 52 weekly tasks and information packages. Receives: Behavioral: Weight loss counseling program |
| Control group | Experimental | Usual care without any interventions. Receives: Behavioral: Weight loss counseling program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Weight change
Measured: Baseline, 1 , 2 and 5 years
Secondary outcomes (1)
Change in eating behavior
emotional eating, uncontrolled eating, cognitive restraint, binge eating symptoms
Measured: Baseline, 1, 2 and 5 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Oct 2013 (estimated)
- Study startFeb 2013
- Primary completionDec 2019
- Study completionDec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Metabolic SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Enrolment
- 574 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Oulu
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01959763
- Sponsor's protocol ID
- 55/2012
- Other IDs
- 083/THL/TE/2012
- Acronym
- PrevMetSyn
- Status last verified
- Oct 2024
- First submitted
- 6 Sep 2013
- Last updated
- 31 Oct 2024
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Rahunen R, Merikallio H, Rinne V, Savolainen MJ, Hukkanen J. Hypertension in Overweight and Obesity: Sex-Specific Role of 4beta-Hydroxycholesterol. J Am Heart Assoc. 2026 Mar 3;15(5):e043913. doi: 10.1161/JAHA.125.043913. Epub 2026 Feb 26.
PubMed 41744113Turkkila E, Pekkala T, Merikallio H, Merikukka M, Heikkila L, Hukkanen J, Oinas-Kukkonen H, Salonurmi T, Teeriniemi AM, Jokelainen T, Savolainen MJ. Five-year follow-up of a randomized weight loss trial on a digital health behaviour change support system. Int J Obes (Lond). 2025 May;49(5):949-953. doi: 10.1038/s41366-025-01742-4. Epub 2025 Mar 15.
PubMed 40089569
Study at a glance
From the registry record, last updated by the sponsor on 31 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevention of the Metabolic Syndrome by a Lifestyle Intervention - an Application of the New Intervention Methods in the Primary Health Care.
- ClinicalTrials.gov ID
- NCT01959763
- Acronym / sponsor ID
- PrevMetSyn / 55/2012
- Conditions
- Metabolic Syndrome, Obesity, Overweight, Cardiovascular Disease
- Keywords
- Metabolic syndrome, obesity, overweight, weight loss intervention, cognitive behavioral therapy, ICT intervention, cardiovascular disease, persuasive systems design
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 574 participants (actual)
- Lead sponsor
- University of OuluUniversity, hospital or other
- Study start
- Feb 2013
- Primary completion
- Dec 2019 (actual)
- Study completion
- Dec 2025 (estimated)
- First posted
- 10 Oct 2013 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This intervention aims to reduce obesity by using new type of nutritional and lifestyle therapy and in parallel, tailored persuasive information and communications technology (ICT)-technology based application. The study hypothesis is that obesity cannot be reduced just by distributing nutritional information. Instead, by influencing also the eating behavior, permanent lifestyle changes can be achieved. The effect of the therapy along the time-line, the health information literacy of the study persons and the changes in it will be studied at different phases of the intervention. The research will be carried out in three main groups of different levels of nutritional therapies with a parallel ICT-intervention and control group for each main group (altogether six groups).
Detailed description
The research objectives of this study: 1) to find the best counseling methods for improving eating behavior (group counseling, tailored web-based counseling), 2) to find the predictors of successful lifestyle changes and weight loss, 3) to find the associations with biological and psychological eating behavior regulation system, 4) to study the long-term effects of the intervention, 5) to investigate the changes to the medications after the intervention . The study hypothesis is that new theoretically valid cognitive-behavioral-therapy -based counseling methods in combination with ICT support based on persuasive design improve eating behavior, weight loss and self-efficacy and reduce risk factors for the metabolic syndrome, type 2 diabetes, coronary heart disease and musculoskeletal factors.
The study population consists of participants with overweight or obesity and at least one risk factor of metabolic syndrome (MetSyn). A population-based sample of 600 participants living in the Oulu area (approx. 200 000 habitants) is collected with the help of the Finnish Population Register Centre.
Inclusion criteria include also the ability to use basic ICT technology (email etc.). Exclusion criteria are certain uncontrolled health factors, such as abnormal laboratory values (thyroid, kidney and liver function tests) or clinically significant illness with contraindication for weight loss or physical activity.
Study visits are at baseline, 1, 2 and 5 years. At the study visit blood samples are drawn at the research laboratory of the Oulu University Hospital. Along with the timeline of the visits the eating behaviour factors (emotional eating, uncontrolled eating and cognitive restraint), health information literacy (HIL), nutrition habits, smoking, alcohol consumption, medication and previous diseases are recorded by a detailed questionnaires sent to study persons by e-mail. The blood pressure, waist diameter, height and weight are also measured during the visit. All the operations have been described in detail and accepted by the regional Ethics Committee of the Northern Ostrobothnia.
The randomization process is two-phased. First the subjects who are included in the study are randomized into 2 different kinds of lifestyle face-to-face counselling groups and one control group. After that they are randomized into users or non-users of the web-based ICT-program "Onnikka". As a summary, there are six different counselling groups: 1) Intensive group counselling, 2) Intensive group counselling with Onnikka, 3) Short term group counselling, 4) Short term counselling with Onnikka, 5) Control group (no intervention at all), and 6) Only Onnikka.
A linear mixed-effect model (LMM) (as primary analysis), where group (six study arms) and time were fixed effect factors are used to examine the differences in weight from baseline to 1, 2 and 5 years adjusting for age and sex. Primary analysis and sensitivity analyses are based on intention-to-treat principles. Primary analysis are also used to examine the differences between ICT groups and non-ICT groups. Group and time interaction are included in the model to examine whether mean change over time is different between groups. If data include missing values, they will be assumed to be completely at random. The same model is used with imputed values (both last observation carried forward (LOCF) and return-to-baseline (RTB) where data are missing and for completers as sensitivity analyses. Area Under the Curve (AUC) analysis is performed to integrate the effect interventions on the weight reduction over the different time points.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Number of arms
- 6
| Arm | Type | Receives |
|---|---|---|
| Weight loss counseling with ICT intervention | Experimental | Behavioral: Weight loss counseling programCognitive behavioral therapy-based weight loss counseling program including 8 group visits. Participant have also persuasive ICT support. |
| Weigth loss counseling | Experimental | Behavioral: Weight loss counseling programCognitive behavioral therapy-based weight loss counseling program including 8 group visits. |
| ELVIRA-based weight loss counseling with ICT intervention | Experimental | Behavioral: Weight loss counseling programWeight loss counseling program based on 2 group visits of ELVIRA counseling method. Participant have also persuasive ICT support. |
| ELVIRA-based weight loss counseling | Experimental | Behavioral: Weight loss counseling programWeight loss counseling program based on 2 group visits of ELVIRA counseling method. |
| ICT-based weight loss counseling | Experimental | Behavioral: Weight loss counseling programICT-based weight loss counseling program with 52 weekly tasks and information packages. |
| Control group | Experimental | Behavioral: Weight loss counseling programUsual care without any interventions. |
Who may qualify
- Ages
- 20 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- BMI 27-35
Key exclusion criteria (3 listed)
- Other concurrent weight loss programs
- Disease which prevents weight loss
- Medication which affects on weight loss
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Weight loss counseling programAlso: PrevMetSyn, Prevent Metabolic SyndromeRandomized study persons are given either one of the two different methods of weight loss counseling program without ICT or with ICT-based counseling. As a control for the study groups one group is receiving only ICT-based counseling and one group does not receive any of the counseling methods. | Behavioural | Control group, ELVIRA-based weight loss counseling, ELVIRA-based weight loss counseling with ICT intervention, ICT-based weight loss counseling, Weight loss counseling with ICT intervention, Weigth loss counseling |
Primary outcome
Weight change
Time frame: Baseline, 1 , 2 and 5 years
1 secondary outcome
Change in eating behavior
Time frame: Baseline, 1, 2 and 5 years
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Oct 2024.
- Derived from this study: PubMed 41744113Rahunen R, Merikallio H, Rinne V, Savolainen MJ, Hukkanen J. Hypertension in Overweight and Obesity: Sex-Specific Role of 4beta-Hydroxycholesterol. J Am Heart Assoc. 2026 Mar 3;15(5):e043913. doi: 10.1161/JAHA.125.043913. Epub 2026 Feb 26.
- Derived from this study: PubMed 40089569Turkkila E, Pekkala T, Merikallio H, Merikukka M, Heikkila L, Hukkanen J, Oinas-Kukkonen H, Salonurmi T, Teeriniemi AM, Jokelainen T, Savolainen MJ. Five-year follow-up of a randomized weight loss trial on a digital health behaviour change support system. Int J Obes (Lond). 2025 May;49(5):949-953. doi: 10.1038/s41366-025-01742-4. Epub 2025 Mar 15.
- Individual participant dataSharing planned: No
Related trials for Metabolic Syndrome
RecruitingObservational study
Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Fanconi Anemia, Inherited Bone Marrow Failure Syndrome
Not yet recruitingPhase 2
Osilodrostat for Glycemic Control in Mild Autonomous Cortisol Secretion (MACS) With Difficult-To-Control Type 2 Diabetes - A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Mild Autonomous Cortisol Secretion (MACS), Diabetes Mellitus (Type 2)
Active, not recruiting
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis
Not yet recruitingObservational study
Clinical Genetics Branch Eligibility Screening Survey
Melanoma, Li-Fraumeni Syndrome
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Weight loss counseling program in people with Metabolic Syndrome and Obesity, run by University of Oulu at 1 site in Finland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 31 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Weight change (time frame: Baseline, 1 , 2 and 5 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01959763, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Oct 2024.